全文获取类型
收费全文 | 103097篇 |
免费 | 7603篇 |
国内免费 | 577篇 |
专业分类
耳鼻咽喉 | 1401篇 |
儿科学 | 2064篇 |
妇产科学 | 1744篇 |
基础医学 | 14761篇 |
口腔科学 | 1460篇 |
临床医学 | 9587篇 |
内科学 | 22880篇 |
皮肤病学 | 2193篇 |
神经病学 | 9547篇 |
特种医学 | 4867篇 |
外科学 | 14316篇 |
综合类 | 1093篇 |
现状与发展 | 1篇 |
一般理论 | 81篇 |
预防医学 | 6880篇 |
眼科学 | 2260篇 |
药学 | 7439篇 |
中国医学 | 473篇 |
肿瘤学 | 8230篇 |
出版年
2023年 | 581篇 |
2022年 | 1406篇 |
2021年 | 2746篇 |
2020年 | 1614篇 |
2019年 | 2421篇 |
2018年 | 2913篇 |
2017年 | 2114篇 |
2016年 | 2679篇 |
2015年 | 3337篇 |
2014年 | 4415篇 |
2013年 | 5174篇 |
2012年 | 8108篇 |
2011年 | 7942篇 |
2010年 | 4642篇 |
2009年 | 4013篇 |
2008年 | 6385篇 |
2007年 | 6477篇 |
2006年 | 6096篇 |
2005年 | 5892篇 |
2004年 | 5172篇 |
2003年 | 4704篇 |
2002年 | 4281篇 |
2001年 | 1284篇 |
2000年 | 1156篇 |
1999年 | 1131篇 |
1998年 | 853篇 |
1997年 | 773篇 |
1996年 | 645篇 |
1995年 | 605篇 |
1994年 | 485篇 |
1993年 | 492篇 |
1992年 | 733篇 |
1991年 | 742篇 |
1990年 | 639篇 |
1989年 | 675篇 |
1988年 | 665篇 |
1987年 | 638篇 |
1986年 | 565篇 |
1985年 | 592篇 |
1984年 | 508篇 |
1983年 | 428篇 |
1982年 | 375篇 |
1981年 | 328篇 |
1980年 | 292篇 |
1979年 | 337篇 |
1978年 | 315篇 |
1977年 | 238篇 |
1976年 | 206篇 |
1974年 | 239篇 |
1973年 | 252篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
Eric M Cheng Andrew Siderowf Kari Swarztrauber Mahmood Eisa Martin Lee Barbara G Vickrey 《Movement disorders》2004,19(2):136-150
Parkinson's disease (PD) is a major cause of disability. To date, there have been no large-scale efforts to measure the quality of PD care because of a lack of quality indicators for conducting an explicit review of PD care processes. We present a set of quality indicators for PD care. Based on a structured review of the medical literature, 79 potential indicators were drafted. Through a two-round modified Delphi process, an expert panel of seven movement disorders specialists rated each indicator on criteria of validity, feasibility, impact on outcomes, room for improvement, and overall utility. Seventy-one quality indicators met validity and feasibility thresholds. Applying thresholds for impact on outcomes, room for improvement, and overall utility, a subset of 29 indicators was identified, spanning dopaminergic therapy, assessment of functional status, assessment and treatment of depression, coordination of care, and medication use. Multivariable analysis showed that overall utility ratings were driven by validity and impact on outcomes (P < 0.01). An expert panel can reach consensus on a set of highly rated quality indicators for PD care, which can be used to assess quality of PD care and guide the design of quality improvement projects. 相似文献
92.
Eric G Butchart Christa Gohlke-B?rwolf 《Journal of the American College of Cardiology》2004,44(5):1143-4; author reply 1144-5
93.
Anjali Shah Eric Eggenberger Robert Zivadinov Olaf Stüve Elliot M. Frohman 《Neurotherapeutics》2007,4(4):627-632
Physicians who treat multiple sclerosis (MS) face the challenge of patients exhibiting ongoing disease activity, including
exacerbations, loss of functional capabilities, intellectual decline, and radiologic progression, despite being on a disease-modifying
agent (DMA). After searching for factors that might at least in part explain these changes—such as nonadherent drug-taking
behavior, or the presence of interfer-on-neutralizing antibodies—some providers may ultimately decide to switch the patient
to another DMA. In most circumstances, patients likely derive only partial effects from these agents, even in the absence
of compromising factors. Thus, a number of factors must be considered in order to intensify the treatment regimen in response
to disease progression. In the context of an inadequate treatment response to a DMA, some clinicians will convert the patient
to an alternative therapy, and others will instead use a second agent in combination with the first (the so-called platform
agent). In the first of this two-part series, we explored the use of anti-inflammatory CS and ACTH to treat MS exacerbations.
Although we underscored the limited availability of evidence-based studies to support specific regimens for this purpose,
there is an even greater paucity of data to support the routine use of these agents in order to achieve chronic disease-modifying
effects in those who continue to deteriorate clinically, radiographically, or both. Without doubt, a number of factors influence
the formulation of combination treatment plan for MS. Nevertheless, we will focus on the rationale and practical schemes that
can be considered for using corticosteroids (CS) (and perhaps even ACTH) in an attempt to modify various domains of ongoing
disease activity. 相似文献
94.
LaVoie Edmond J.; Cai Zhen-Wei; Meschter Carol L.; Weyand Eric H. 《Carcinogenesis》1994,15(10):2131-2135
Fluoranthene (FA) is frequently among the more abundant componentsdetected in environmental mixtures of polycyclic aromatic hydrocarbons.Several methylated fluoranthenes, although less prevalent thanFA, have also been detected as environmental pollutants. WhileFA is inactive as a tumorigenic agent on mouse skin, it doesinduce lung and liver tumors in newborn mice. Among the fiveisomers of methylfluoranthene, only 2-methylfluoranthene (2-MeFA)and 3-methylfluoranthene (3-MeFA) are active as tumor initiatorson mouse skin. A comparative bioassay was performed to determinethe relative tumorigenic activity of FA, 2-MeFA and 3-MeFA innewborn CD-1 mice. All three compounds were assayed at dosesof 3.46 and 17.3 µmol. The bioassay was terminated whenmice were 1 year old. At a dose of 17.3 µmol, FA and 2-MeFAinduced a similar incidence of lung tumors (6596%) inboth male and female mice. However, tumor multiplicity in thelung was different between FA and 2-MeFA. At a dose of 17.3µmol, the multiplicity of lung tumors observed for miceadministered 2-MeFA ranged from 3.04 to 3.94 tumors per mouse.In contrast, animals treated with FA developed only an averageof 1.122.45 tumors per mouse. 3-MeFA did not induce astatistically significant incidence of lung tumors in eithermale or female mice. All three compounds when administered tonewborn mice did induce a significant incidence of liver tumorsamong male mice. The relative tumorigenic potency observed wasFA 5 相似文献
95.
Andrew M Speer Mark W Willis Peter Herscovitch Margaret Daube-Witherspoon Jennifer Repella Shelton Brenda E Benson Robert M Post Eric M Wassermann 《Neuropsychopharmacology》2003,54(8):818-825
BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) affects the excitability of the motor cortex and is thought to influence activity in other brain areas as well. We combined the administration of varying intensities of 1-Hz rTMS of the motor cortex with simultaneous positron emission tomography (PET) to delineate local and distant effects on brain activity. METHODS: Ten healthy subjects received 1-Hz rTMS to the optimal position over motor cortex (M1) for producing a twitch in the right hand at 80, 90, 100, 110, and 120% of the twitch threshold, while regional cerebral blood flow (rCBF) was measured using H(2)(15)O and PET. Repetitive transcranial magnetic stimulation (rTMS) was delivered in 75-pulse trains at each intensity every 10 min through a figure-eight coil. The regional relationship of stimulation intensity to normalized rCBF was assessed statistically. RESULTS: Intensity-dependent rCBF increases were produced under the M1 stimulation site in ipsilateral primary auditory cortex, contralateral cerebellum, and bilateral putamen, insula, and red nucleus. Intensity-dependent reductions in rCBF occurred in contralateral frontal and parietal cortices and bilateral anterior cingulate gyrus and occipital cortex. CONCLUSIONS: This study demonstrates that 1-Hz rTMS delivered to the primary motor cortex (M1) produces intensity-dependent increases in brain activity locally and has associated effects in distant sites with known connections to M1. 相似文献
96.
Percutaneous bone marrow grafting of fractures and bony defects. An experimental study in rabbits 总被引:6,自引:0,他引:6
D Paley M C Young A M Wiley V L Fornasier R W Jackson 《Clinical orthopaedics and related research》1986,(208):300-312
Since bone marrow has been shown to contain osteoprogenitor cells, an experiment was devised to test its effects when injected percutaneously into osteotomies and 2-cm bony defects produced in rabbit radii. The parameters tested included callus volume, breaking load, tensile strength, and cross-sectional area of callus at the fracture or bony defect site. At two weeks postgrafting callus volume was significantly higher (p less than 0.01) in the grafted radii than in the contralateral saline controls. By four weeks all four parameters were significantly greater in the bone marrow grafted radii than in the contralateral saline controls. Serial radiographs and histology confirm this advanced fracture healing in the grafted bones. The earlier and more abundant callus, at the bone marrow grafted sites, was felt to provide earlier and greater stability, resulting in decreased early healing time when contrasted with the saline controls. Similarly, the bony defects that were grafted with bone marrow united by a bony bridge, whereas the saline controls did not. Percutaneous bone marrow grafting is a simple semi-invasive technique that may have potential clinical applications. 相似文献
97.
98.
99.
Striatal inhomogeneities and basal ganglia function 总被引:5,自引:0,他引:5
100.
Management of chronic lunotriquetral ligament tears 总被引:1,自引:0,他引:1
Treatment of chronic disruptions of the lunotriquetral (LT) ligament is not well-defined. Eleven patients treated by LT fusion with use of a compression screw are reported. The injury frequently resulted from hyperextension of the wrist. Pain on the ulnar side of the wrist, limited motion, and tenderness over the LT joint exacerbated by ballottement were present. Standard radiographs were normal. Arthrography showed the ligamentous tear in all cases. After operation, immobilization was continued until fusion was apparent radiographically. Fusion was achieved in all cases between 2 and 5 months. Four patients were free of pain, four patients had pain only at the extremes of motion, and three patients had persistent pain. Mean wrist motion was as follows (preoperative/postoperative): flexion (53 degrees/45 degrees), extension (60 degrees/49 degrees), radial deviation (17 degrees/21 degrees), and ulnar deviation (25 degrees/18 degrees). Maximum grip strength as a percentage of the uninjured side was 73% preoperatively and 59% postoperatively. LT tears can exist de novo or as part of the ulnar impaction syndrome; a method for differentiation is presented. 相似文献